Abstract
Abstract
Objectives
In the first year of pandemic measures, opioid-related deaths across Ontario’s (ON) 34 public health units (PHUs) increased by 60%. Death rates for all seven Northern ON PHUs were above the provincial average. This study describes and compares factors surrounding opioid-related deaths before and after pandemic measures were introduced, for Northern ON compared to the rest of ON.
Methods
Aggregate data were provided for Northern ON and the rest of the province by the Office of the Chief Coroner/Ontario Forensic Pathology Services. Opioid-related deaths were cohorted by date of death for the year before and after pandemic measures were introduced on March 16, 2020. Chi-square tests were used to compare between cohorts and geographies to determine significant differences for each variable, and for dichotomized levels within variables. P-values < 0.05 were considered statistically significant a priori.
Results
In Northern ON, the number of opioid-related deaths approximately doubled from the pre-pandemic cohort (n = 185) to the early pandemic cohort (n = 365). Compared to the rest of ON, higher proportions of deaths occurred in Northern ON among individuals who lived and died in private residences, among women (although the majority of decedents were male) and among individuals employed in mining, quarrying, and oil and gas industries. Compared to the pre-pandemic year, in Northern ON, higher proportions of opioid-related deaths involved fentanyl and stimulants as direct contributors, and the majority involved evidence of inhaled drugs.
Conclusion
Differences between the circumstances of death in Northern ON and in the rest of ON suggest opportunities to tailor interventions.
Funder
Public Health Agency of Canada
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Albion, C., Shkrum, M., & Cairns, J. (2010). Contributing factors to methadone-related deaths in Ontario. The American Journal of Forensic Medicine and Pathology, 31(4), 313–319. https://doi.org/10.1097/PAF.0b013e3181ca4b1e
2. Ali, F., Russell, C., Nafeh, F., Rehm, J., LeBlanc, S., & Elton-Marshall, T. (2021). Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada. The International Journal on Drug Policy, 93, 103237. https://doi.org/10.1016/j.drugpo.2021.103237
3. Assembly of First Nations. (2019). First Nations health priorities to reducing problematic opioid use. Ottawa, Ontario. https://afn.bynder.com/m/1de9ba2a97305ca4/original/2019-AFN-Opioid-Strategy-Report.pdf. Accessed 28 Mar 2024
4. Brave Technology Co-op. (2024). Brave overdose detection system: For communities tackling the overdose crisis. Vancouver, British Columbia. https://www.brave.coop/overdose-detection-system. Accessed 25 March 2024.
5. Buajitti, E., Watson, T., Norwood, T., Kornas, K., Bornbaum, C., Henry, D., & Rosella, L. (2019). Regional variation of premature mortality in Ontario, Canada: A spatial analysis. Population Health Metrics, 17(1), 9. https://doi.org/10.1186/s12963-019-0193-9